| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/10/2007 | US20070104712 Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors |
| 05/10/2007 | US20070104661 Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
| 05/10/2007 | CA2627912A1 Treatment of diabetes |
| 05/10/2007 | CA2627598A1 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 05/10/2007 | CA2609985A1 Modulation of cell barrier dysfunction |
| 05/09/2007 | EP1783224A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/09/2007 | EP1783221A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1782859A2 Pharmaceutical use of substituted pyrazolo [1,5- a]pyrimidines |
| 05/09/2007 | EP1782832A1 Remedy for diabetes |
| 05/09/2007 | EP1782831A1 External preparation |
| 05/09/2007 | EP1782830A1 Preventive and/or remedy for lower urinary tract diseases containing ep4 agonist |
| 05/09/2007 | EP1782829A1 Preventive and/or remedy for hyperkalemia containing ep4 agonist |
| 05/09/2007 | EP1782828A1 Progression inhibitor for disease attributed to abnormal accumulation of liver fat |
| 05/09/2007 | EP1782825A2 Treatment of glycogen storage diseases type II |
| 05/09/2007 | EP1782813A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 05/09/2007 | EP1782804A1 Medicinal composition as immunosuppressant |
| 05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
| 05/09/2007 | EP1782798A2 Ascending-dose dosage form |
| 05/09/2007 | EP1781332A1 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 05/09/2007 | EP1781331A1 Use of agonists and antagonists of beta-adrenoceptors for treating arterial diseases |
| 05/09/2007 | EP1781330A1 Compositions containing a capillary active system with application-related differentiability, and the use thereof |
| 05/09/2007 | EP1781298A1 Pharmaceutical combinations containing benzoxazine for treating respiratory diseases |
| 05/09/2007 | EP1781276A2 Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain |
| 05/09/2007 | EP1781267A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 05/09/2007 | EP1573031A4 Androgen regulated nucleic acid molecules and encoded proteins |
| 05/09/2007 | EP1487434B1 Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin |
| 05/09/2007 | EP1450799B9 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 05/09/2007 | EP1313882B1 Diagnosis and treatment of prostate cancer |
| 05/09/2007 | EP1244456B1 A pyrrolidineacetamide derivative for treatment of chronic or neuropathic pain |
| 05/09/2007 | EP1180143B1 In vitro methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues, pharmaceutical compositions related thereto |
| 05/09/2007 | EP1169058B1 Insulin-like growth factor binding protein-4 protease |
| 05/09/2007 | EP1168912B1 Organ arrest, protection and preservation |
| 05/09/2007 | EP0969720B1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/09/2007 | EP0708660B1 Compounds useful for preparing prodrugs of protein tyrosine kinase inhibitors |
| 05/09/2007 | EP0673653B1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 05/09/2007 | CN1961283A Systems and methods for providing a stem cell bank |
| 05/09/2007 | CN1961073A Truncated DANCE, DANCE complex and method of using these |
| 05/09/2007 | CN1960825A Functionalized colloidal metal compositions and methods |
| 05/09/2007 | CN1960764A Combinations comprising a S1P receptor agonist and a JAK3 kinase inhibitor |
| 05/09/2007 | CN1960763A Anti-vaginitis compositions |
| 05/09/2007 | CN1960762A Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 05/09/2007 | CN1960761A Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 05/09/2007 | CN1960760A Combinations comprising antimuscarinic agents and corticosteroids |
| 05/09/2007 | CN1960759A Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 05/09/2007 | CN1960758A Remedy or preventive for arthritis |
| 05/09/2007 | CN1960757A Composition for increasing body height |
| 05/09/2007 | CN1960735A Use of drug combinations for treating insulin resistance |
| 05/09/2007 | CN1960730A Treatment with irinotecan and EGFR-inhibitor |
| 05/09/2007 | CN1960720A Novel use of peptide compounds for treating amyotrophic lateral sclerosis |
| 05/09/2007 | CN1960715A 营养制剂 Nutritional formulations |
| 05/09/2007 | CN1958074A Injectable block copolymer hydrogel of temperature sensibilityú¿epsi ¿C caprolactone - glycolideú®- polyethyleneglycol |
| 05/09/2007 | CN1958073A External use medicament for onychomycosis in fingernails or toe nails |
| 05/09/2007 | CN1958001A Medication for treating high blood pressure |
| 05/09/2007 | CN1957928A Controlled release preparation of clinical treating medication, and fabricating method |
| 05/09/2007 | CN1957923A A kind of controlled release injection of carried fluorouracil and synergis |
| 05/09/2007 | CN1957922A Controlled release agent of containing fluorouracil and synergis |
| 05/09/2007 | CN1957921A Controlled release injection of carried fluorouracil and synergis |
| 05/09/2007 | CN1957920A Anti cancer controlled release agent of carried fluorouracil and synergist |
| 05/09/2007 | CN1957916A Anti cancer controlled release agent of carried interstitial hydrolytic agent and derivative of Epothilone |
| 05/09/2007 | CN1957915A Anti cancer controlled release agent of carried interstitial hydrolytic agent and medication of cell toxin |
| 05/09/2007 | CN1957914A Anti cancer controlled release agent of carried interstitial hydrolytic agent and medication of cell elements |
| 05/09/2007 | CN1957913A Composition of anti cancer medication prepared from carried platinum category compound and consubstantial hydrolytic agent |
| 05/09/2007 | CN1957912A Anti cancer controlled release formulation of containing interstitial hydrolytic agent |
| 05/09/2007 | CN1957911A Controlled release formulation for anti entity tumour |
| 05/09/2007 | CN1957910A Anti cancer controlled release formulation of containing consubstantial hydrolytic agent |
| 05/09/2007 | CN1957909A Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
| 05/09/2007 | CN1314390C Pharmaceutical dosage form with multiple coatings |
| 05/09/2007 | CN1314361C Joint healthy beverage or food and preparation thereof |
| 05/08/2007 | USRE39614 Canine IL-4 immunoregulatory proteins and uses thereof |
| 05/08/2007 | US7216041 Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket |
| 05/08/2007 | US7214826 N-methyl-3-hydroxy-4,4-dimethyl-2-(2'naphthyl)pentylamine; potent, wide-spectrum antidepressant and treating anxiety disorders |
| 05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 05/08/2007 | US7214790 Genes and proteins encoded thereby |
| 05/08/2007 | US7214788 Insect inhibitory Bacillus thuringiensis proteins, fusions, and methods of use therefor |
| 05/08/2007 | US7214711 Method of treating migraine headache without aura |
| 05/08/2007 | US7214709 Taste; stomach sensitivity; side effect reduction |
| 05/08/2007 | US7214707 Dimeric compounds and their use as anti-viral agents |
| 05/08/2007 | US7214692 Medical use for tachykinin antagonists |
| 05/08/2007 | US7214684 Administering to a human a therapeutically effective amount of descarboethoxyloratadine |
| 05/08/2007 | US7214665 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| 05/08/2007 | US7214658 Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection |
| 05/08/2007 | US7214507 Plant enzymes for bioconversion |
| 05/08/2007 | US7214381 Combination of a saturated or unsaturated fatty alcohol or fatty acid; a C1/C4 alkanol; a polyalcohol in particular propylenglycol; water; and optionally a monoalkylether of diethylene glycol as a permeation enhancer |
| 05/08/2007 | US7214380 Composition of an allergen that causes Th2-type T cell response in a susceptible individual, Listeria adjuvant, and a pharmaceutically acceptable carrier; treating allergies associated with an established allergen specific Th2-type T cell response |
| 05/08/2007 | US7214370 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 05/08/2007 | CA2427764C Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 05/08/2007 | CA2306837C Treatment of female sexual dysfunction |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/08/2007 | CA2267498C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 05/08/2007 | CA2262267C Anti-migraine pharmaceutical compositions and process of using |
| 05/03/2007 | WO2007049828A1 Therapeutic agent for unstable cerebrospinal pressure syndrome |
| 05/03/2007 | WO2007049825A1 P2x4 receptor antagonist |
| 05/03/2007 | WO2007049783A1 Method of fracture healing |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049732A1 Method for prevention and/or treatment of rheumatoid arthritis |
| 05/03/2007 | WO2007049731A1 Novel cell membrane-permeable peptide |
| 05/03/2007 | WO2007049624A1 Preventives/remedies for cancer |
| 05/03/2007 | WO2007049542A1 METHOD FOR PREDICTION OF EFFECTIVENESS OF RAR-α AGONIST |
| 05/03/2007 | WO2007049424A1 Hepatic fibrosis inhibitor |